Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Efficacy and safety assessment of glandular augmentation with hyaluronic acid for premature ejaculation

Efficacy and safety assessment of glandular augmentation with hyaluronic acid for premature... Glandular augmentation (GA) with hyaluronic acid (HA) is a newly developed, minimally invasive therapy for patients with premature ejaculation (PE); however, evidence supporting its efficacy is scarce. To provide a comprehensive profile of GA with HA gel in managing PE, 184 patients with PE who received GA with HA gel therapy from October 2017 to November 2019 were included and followed up for 1 year. The Fan technique was applied. Intravaginal Ejaculation Latency Time (IELT), Chinese Index of Premature Ejaculation‐5(CIPE‐5) and Visualised Satisfaction Index (VSI) of sexual experience were assessed at initial and 1‐, 3‐, 6‐ and 12‐month post injection. A total of 71 patients with primary PE (pPE, 38.6%) and 113 patients with acquired PE (aPE, 61.4%) were enrolled. The mean IELT increased to 100.7 ± 43.2 s(p < .05) for pPE patients and 359.2 ± 87.1 s (p < .05) for aPE patients 1‐month post injection and remained significantly higher at the end point with acceptable attenuation. The mean CIPE‐5 score increased to 17.6 ± 6.4 (p < .05) in the 1st month and remained steady. The VSI scores increased to 6.6 ± 1.0 (p < .05) for patients with pPE and 7.7 ± 1.2 (p < .01) for patients with aPE. Increments in VSI in patients with aPE were significantly higher than those in patients with pPE (p < .01). No severe complications were noted. GA with HA may be an effective and safe method to treat PE. Patients with acquired PE were also more satisfied post treatment. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Andrologia Wiley

Efficacy and safety assessment of glandular augmentation with hyaluronic acid for premature ejaculation

Download PDF
7 pages

Loading next page...
 
/lp/wiley/efficacy-and-safety-assessment-of-glandular-augmentation-with-ezG3J8XB80

References (31)

Publisher
Wiley
Copyright
© 2022 Wiley‐VCH GmbH
ISSN
0303-4569
eISSN
1439-0272
DOI
10.1111/and.14435
Publisher site
See Article on Publisher Site

Abstract

Glandular augmentation (GA) with hyaluronic acid (HA) is a newly developed, minimally invasive therapy for patients with premature ejaculation (PE); however, evidence supporting its efficacy is scarce. To provide a comprehensive profile of GA with HA gel in managing PE, 184 patients with PE who received GA with HA gel therapy from October 2017 to November 2019 were included and followed up for 1 year. The Fan technique was applied. Intravaginal Ejaculation Latency Time (IELT), Chinese Index of Premature Ejaculation‐5(CIPE‐5) and Visualised Satisfaction Index (VSI) of sexual experience were assessed at initial and 1‐, 3‐, 6‐ and 12‐month post injection. A total of 71 patients with primary PE (pPE, 38.6%) and 113 patients with acquired PE (aPE, 61.4%) were enrolled. The mean IELT increased to 100.7 ± 43.2 s(p < .05) for pPE patients and 359.2 ± 87.1 s (p < .05) for aPE patients 1‐month post injection and remained significantly higher at the end point with acceptable attenuation. The mean CIPE‐5 score increased to 17.6 ± 6.4 (p < .05) in the 1st month and remained steady. The VSI scores increased to 6.6 ± 1.0 (p < .05) for patients with pPE and 7.7 ± 1.2 (p < .01) for patients with aPE. Increments in VSI in patients with aPE were significantly higher than those in patients with pPE (p < .01). No severe complications were noted. GA with HA may be an effective and safe method to treat PE. Patients with acquired PE were also more satisfied post treatment.

Journal

Andrologia – Wiley

Published: Aug 1, 2022

Keywords: glandular augmentation; hyaluronic acid; premature ejaculation

There are no references for this article.